Skip to content

Clinical effect study of Babaodan capsule combined with antibiotics on acute pyelonephritis

Clinical effect study of Babaodan capsule combined with antibiotics on acute pyelonephritis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004704
Enrollment
Unknown
Registered
2021-04-07
Start date
2021-05-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pyelonephritis

Interventions

Sponsors

Shantou Central hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for acute pyelonephritis; 2.Syndrome differentiation is bladder damp-heat syndrome; 3.Urine bacterial cultures are all positive; 4.Those who know and sign the consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.People suffering from mental illness; 3.People with renal failure; 4.Accompanied by urinary tract obstruction or deformity; 5.Systemic infection; 6.Those who have taken other related drugs in the past 2 weeks or are participating in clinical trials of other drugs; 7.Patients with drug allergy.

Design outcomes

Primary

MeasureTime frame
Adverse reaction;Main symptoms and signs and comprehensive curative effect;Urine culture results;

Countries

China

Contacts

Public ContactLan Kaijian

Shantou Central Hospital

kles@foxmail.com+86 13502769929

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026